scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.

Scleroderma Management

Follow Up

  • Patients with localized scleroderma with deep tissue lesions should have an annual monitoring even after treatment cessation as the disease may relapse
  • Re-evaluation of symptomatic treatment every 4-6 months should be done to prevent complications or further deterioration
  • Prognosis is better with localized scleroderma than with systemic scleroderma
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 19 hours ago
For individual with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
2 days ago
Percutaneous coronary intervention (PCI), compared with coronary artery bypass grafting (CABG), in the revascularization of left main coronary artery (LMCA) disease may lead to death, myocardial infarction (MI), or stroke in patients with moderate or severe left ventricular (LV) dysfunction, reveals a study.
16 Sep 2020
XOFLUZA – Baloxavir marboxil 20 mg and 40 mg FC tab